Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial
Background Two-six percentage of vasectomized men will ultimately seek vasectomy reversal, which late stricture and obstruction after operation are relatively common. To find a method for improving vasovasostomy outcomes, we used intra-operative local mitomycin-C (MMC) preventing possible fibrosi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Royan Institute (ACECR), Tehran
2019-10-01
|
Series: | International Journal of Fertility and Sterility |
Subjects: | |
Online Access: | http://www.ijfs.ir/article_45554_31dddbdc07f5b8b64aa4deca64514024.pdf |
id |
doaj-4cb7a5eae27f4c8b99d7af5ab704fe2f |
---|---|
record_format |
Article |
spelling |
doaj-4cb7a5eae27f4c8b99d7af5ab704fe2f2020-11-25T04:10:40ZengRoyan Institute (ACECR), TehranInternational Journal of Fertility and Sterility2008-076X2008-07782019-10-0113324024410.22074/ijfs.2019.566445554Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical TrialFarzad Allameh0Hamidreza Qashqai1Hamzeh Mazaherylaghab2Jalil Hosseini3Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IranUrology Department, Imam Sajjad Hospital, Iran University of Medical Sciences, Shahriar, Iran4Faculty of Medicine, Hamedan University of Medical Sciences, Hamedan, IranMen's Health and Reproductive Health Research Center (MHRHRC), Reconstructive Urology Department, Shohada-e-Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, IranBackground Two-six percentage of vasectomized men will ultimately seek vasectomy reversal, which late stricture and obstruction after operation are relatively common. To find a method for improving vasovasostomy outcomes, we used intra-operative local mitomycin-C (MMC) preventing possible fibrosis and stricture. Materials and Methods In this randomized clinical trial, 44 patients were assigned to two groups randomly during a one-year study and the data of 40 patients were analyzed. The patients were followed up for 6 months after surgery. The case group (n=19) was treated by vasovasostomy with intra-operative local MMC. The control group (n=21) underwent standard vasovasostomy. Results Mean sperm count in MMC group was significantly higher than the controls. The sperm count of more than 20 million/ml was respectively 53% and 14% in MMC and control groups. In a subgroup where the interval between vasectomy and reversal was 5-10 years, post-reversal azoospermia was absent in MMC group, but 50% of the controls were still azoospermic. In addition, 80% of MMC group had more than 20 million/ml sperms, but all of the controls had less than 20 million/ml sperms. No significant complication was seen. Conclusion Intra-operative local MMC in vasovasostomy can be regarded as a safe and efficient technique which has several advantages including lower cost. Increase of sperm count is the main effect of local MMC applica- tion that is more prominent when the interval between vasectomy and reversal is 5-10 years (Registration number: IRCT2015092324166N1).http://www.ijfs.ir/article_45554_31dddbdc07f5b8b64aa4deca64514024.pdfclinical trialmitomycin csperm countvasectomy reversalvasovasostomy |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Farzad Allameh Hamidreza Qashqai Hamzeh Mazaherylaghab Jalil Hosseini |
spellingShingle |
Farzad Allameh Hamidreza Qashqai Hamzeh Mazaherylaghab Jalil Hosseini Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial International Journal of Fertility and Sterility clinical trial mitomycin c sperm count vasectomy reversal vasovasostomy |
author_facet |
Farzad Allameh Hamidreza Qashqai Hamzeh Mazaherylaghab Jalil Hosseini |
author_sort |
Farzad Allameh |
title |
Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial |
title_short |
Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial |
title_full |
Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial |
title_fullStr |
Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial |
title_full_unstemmed |
Efficacy of Intraoperative Mitomycin-C in Vasovasostomy Procedure: A Randomized Clinical Trial |
title_sort |
efficacy of intraoperative mitomycin-c in vasovasostomy procedure: a randomized clinical trial |
publisher |
Royan Institute (ACECR), Tehran |
series |
International Journal of Fertility and Sterility |
issn |
2008-076X 2008-0778 |
publishDate |
2019-10-01 |
description |
Background Two-six percentage of vasectomized men will ultimately seek vasectomy reversal, which late stricture and obstruction after operation are relatively common. To find a method for improving vasovasostomy outcomes, we used intra-operative local mitomycin-C (MMC) preventing possible fibrosis and stricture. Materials and Methods In this randomized clinical trial, 44 patients were assigned to two groups randomly during a one-year study and the data of 40 patients were analyzed. The patients were followed up for 6 months after surgery. The case group (n=19) was treated by vasovasostomy with intra-operative local MMC. The control group (n=21) underwent standard vasovasostomy. Results Mean sperm count in MMC group was significantly higher than the controls. The sperm count of more than 20 million/ml was respectively 53% and 14% in MMC and control groups. In a subgroup where the interval between vasectomy and reversal was 5-10 years, post-reversal azoospermia was absent in MMC group, but 50% of the controls were still azoospermic. In addition, 80% of MMC group had more than 20 million/ml sperms, but all of the controls had less than 20 million/ml sperms. No significant complication was seen. Conclusion Intra-operative local MMC in vasovasostomy can be regarded as a safe and efficient technique which has several advantages including lower cost. Increase of sperm count is the main effect of local MMC applica- tion that is more prominent when the interval between vasectomy and reversal is 5-10 years (Registration number: IRCT2015092324166N1). |
topic |
clinical trial mitomycin c sperm count vasectomy reversal vasovasostomy |
url |
http://www.ijfs.ir/article_45554_31dddbdc07f5b8b64aa4deca64514024.pdf |
work_keys_str_mv |
AT farzadallameh efficacyofintraoperativemitomycincinvasovasostomyprocedurearandomizedclinicaltrial AT hamidrezaqashqai efficacyofintraoperativemitomycincinvasovasostomyprocedurearandomizedclinicaltrial AT hamzehmazaherylaghab efficacyofintraoperativemitomycincinvasovasostomyprocedurearandomizedclinicaltrial AT jalilhosseini efficacyofintraoperativemitomycincinvasovasostomyprocedurearandomizedclinicaltrial |
_version_ |
1724419732563558400 |